PDK1/Akt/Flt Dual Pathway Inhibitor

Code: 521275-5MG D2-231

Biochem/physiol Actions

Primary TargetBoth PDK1 and Akt activities

Reversible: no

Product does not compete with ATP.

Target IC50: 1.05, 1.91, and...


 Read more

Your Price
€417.18 EACH
€513.13 inc. VAT

Biochem/physiol Actions

Primary TargetBoth PDK1 and Akt activities

Reversible: no

Product does not compete with ATP.

Target IC50: 1.05, 1.91, and 0.43 µM for AML with wild-type Flt3, single mutant ITD/D835, and double mutant Flt3-ITD-TDK, respectively

Cell permeable: yes

General description

A cell-permeable compound that selectively induces apoptosis in AML (Acute Myelogenous Leukemia) with little effect on normal CD34+ AML progenitor cells. Shown to directly inhibit both PDK1 and Akt activities in in vitro kinase assays in a dose-dependent manner and block cellular phosphorylation of Akt at both Ser473 and Thr308. The dual inhibition nature against both PDK1/Akt and Flt3/PIM signaling pathways allows effective killing of AML cells (Average IC50 = 1.05, 1.91, and 0.43 µM for AML with wild-type Flt3, single mutant ITD/D835, and double mutant Flt3-ITD-TDK, respectively) that are otherwise resistant to inhibitors that target only the PDK1/Akt pathway.

A cell-permeable compound that selectively induces apoptosis in AML (Acute Myelogenous Leukemia) with little effect on normal CD34+ AML progenitor cells. Shown to directly inhibit both PDK1 and Akt activities in in vitro kinase assays in a dose-dependent manner and block cellular phosphorylation of Akt at both Ser473 and Thr308. The dual inhibition nature against both PDK1/Akt and Flt3/PIM signaling pathways allows effective killing of AML cells (Average IC50 = 1.05, 1.91, and 0.43 µM for AML with wild-type Flt3, single mutant ITD/D835, and double mutant Flt3-ITD-TDK, respectively) that are otherwise resistant to inhibitors that target only the PDK1/Akt pathway. CAS. No. 331253-86-2 and 329710-24-9.

CAS. Nos. 331253-86-2 and 329710-24-9 (two isomers)

Legal Information

CALBIOCHEM is a registered trademark of Merck KGaA, Darmstadt, Germany

Other Notes

Zeng, Z., et al. 2006. Cancer Res.66, 3737. Koul, D., et al. 2006. Mol. Cancer Ther.5, 637.Mandal. M., et al. 2006. Oral Oncol.42, 430.Mandal. M., et al. 2005. Br. J. Cancer92, 1899.

Packaging

Packaged under inert gas

5 mg in Plastic ampoule

Warning

Toxicity: Irritant (B)

assay≥98% (sum of two isomers, HPLC)
coloryellow
formsolid
manufacturer/tradenameCalbiochem®
Quality Level100
shipped inambient
solubilityDMSO: 10 mg/mL
storage conditionprotect from light, OK to freeze
storage temp.2-8°C
Cas Number331253-86-2
This product has met the following criteria to qualify for the following awards:



HAVE AN ACCOUNT? LOGIN

GUEST CHECKOUT

Proceed as a guest. You will have the option to register to access exclusive pricing and stock availability features after checkout.